NEWAMSTERDAM PHARMA COMPANY N.V. WARRANT reports a Return on Equity (ROE) of -31.98%.

What is NAMSW's dividend yield?

NEWAMSTERDAM PHARMA COMPANY N.V. WARRANT offers a dividend yield of 0.00%.

What is NAMSW's Deepscope Quality Score?

Deepscope rates NAMSW's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy NAMSW?

Deepscope's AI Timing Score for NAMSW is 3 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Cổ phiếu NAMSW (NASDAQ) | NEWAMSTERDAM PHARMA COMPANY N.V. WARRANT

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-05 | FS: 2026-03-31)

NAMSW

NEWAMSTERDAM PHARMA COMPANY N.V. WARRANT

US:NASDAQ STOCK News 98

USD 19.72

-1.59 (-7.46%) Day Change

Watchlist Portfolio Compare Chart

0.00

D/E

-32.0%

ROE

-29.0%

ROA

0.00%

Div Yield

NEWAMSTERDAM PHARMA COMPANY N.V. WARRANT
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 19.72 Price -1.59 (-7.46%) Day Change	NEWS SCORE: 98

NAMSW Chất lượng tổng thể của cố phiếu Không tốt lắm ( Chất lượng = 54) và Thời điểm mua ...(Sign In to See)...

Loading chart...

54 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE
Biên lợi nhuận ròng tương đối thấp.
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt , và khả năng kiếm lợi nhuận Khá , ...

Yếu tố Chất lượng

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	98
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	19.72
PBV / Sector	N/A / N/A
Earning Per Share	N/A

PE / Sector	N/A / N/A
PEG or PE/Growth / Sector	N/A / N/A
Average 1M Daily Value	0.04 M GREAT
Average 1W Daily Value	0.01 M GREAT

Yếu tố Kỹ thuật

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

60%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-942.76 / N/A
NPM Average (%) / Sector	-731.31 / N/A
NPM Change Average (%) / Sector	1,403.68 / N/A
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-29.04 / N/A
ROA Average (%) / Sector	-27.84 / N/A
ROA Change Average (%) / Sector	234.22 / N/A GREAT
ROE (%) / Sector	-31.98 / N/A
ROE Average (%) / Sector	-32.06 / N/A
ROE Change Average (%) / Sector	254.62 / N/A GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / N/A
Dividend Average (%) / Sector	N/A / N/A
Dividend Change Average (%) / Sector	N/A / N/A

Chi tiết đăng ký

Analyze Date	2026-06-06 09:09:04
Symbol	NAMSW
Name	NEWAMSTERDAM PHARMA COMPANY N.V. WARRANT
Sector
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	N/A / N/A

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Gooimeer 2-35, Naarden, Netherlands, 1411 DC

Phone: 31 35 206 2971

Website: https://www.newamsterdampharma.com

Employees: 100

Sector: -

Description: NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.